Raspberry seed flour attenuates high-sucrose diet-mediated hepatic stress and adipose tissue inflammation

Journal of Nutritional Biochemistry

Volumn 32, Issue , 2016, Pages 64-72

  Kang, Inhae ^a   Espín, Juan Carlos ^b   Carr, Timothy P ^a   Tomás Barberán, Francisco A ^b   Chung, Soonkyu ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Adipose inflammation; Ellagic acid; Hepatic stress; Obesity; Raspberry seed flour

Indexed keywords

GLUCOSE; SUCROSE; ANTIOXIDANT; BIOLOGICAL MARKER; ELLAGIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SUGAR INTAKE;

ADIPOSE TISSUE; ADIPOSE TISSUE INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FLOUR; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYDROLYSIS; INFLAMMATION; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLANT SEED; RASPBERRY; RASPBERRY SEED FLOUR; SOFT TISSUE INFLAMMATION; UPREGULATION; ADVERSE EFFECTS; ANALYSIS; ANIMAL; C57BL MOUSE; CARBOHYDRATE LOADING DIET; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; DIETARY SUPPLEMENT; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; LIPID DIET; LIVER; METABOLISM; OBESITY; PANNICULITIS; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; RUBUS; SUGAR INTAKE; TUMOR CELL LINE;

ADIPOSITY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BIOMARKERS; CELL LINE, TUMOR; DIET, CARBOHYDRATE LOADING; DIET, HIGH-FAT; DIETARY SUCROSE; DIETARY SUPPLEMENTS; ELLAGIC ACID; ENDOPLASMIC RETICULUM STRESS; HUMANS; INTRA-ABDOMINAL FAT; LIVER; MALE; MICE, INBRED C57BL; OBESITY; OXIDATIVE STRESS; PANNICULITIS; RANDOM ALLOCATION; RUBUS; SEEDS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84961741440     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.02.006     Document Type: Article

References (45)

1. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461s-465s.
2. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999, 4:597-609.
3. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
4. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Hu F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121:1356-1364.
5. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000, 71:412-433.
6. Carden T.J., Carr T.P. Food availability of glucose and fat, but not fructose, increased in the U.S. between 1970 and 2009: analysis of the USDA food availability data system. Nutr J 2013, 12:130.
7. Malik V.S., Schulze M.B., Hu F.B. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006, 84:274-288.
8. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
9. Lee J.H., Johnson J.V., Talcott S.T. Identification of ellagic acid conjugates and other polyphenolics in muscadine grapes by HPLC-ESI-MS. J Agric Food Chem 2005, 53:6003-6010.
10. Vasudev S.S., Ahmad F.J., Khar R.K., Bhatnagar A., Kamal Y.T., Talegaonkar S., et al. Validated HPLC method for the simultaneous determination of taxol and ellagic acid in a Punica granatum fruit extract containing combination formulation. Pharmazie 2012, 67:834-838.
11. Adams L.S., Zhang Y., Seeram N.P., Heber D., Chen S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila) 2010, 3:108-113.
12. Losso J.N., Bansode R.R., Trappey A., Bawadi H.A., Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 2004, 15:672-678.
13. Aiyer H.S., Gupta R.C. Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Cancer Prev Res (Phila) 2010, 3:727-737.
14. Park S.H., Kim J.L., Lee E.S., Han S.Y., Gong J.H., Kang M.K., et al. Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages. J Nutr 2011, 141:1931-1937.
15. Hseu Y.C., Chou C.W., Senthil Kumar K.J., Fu K.T., Wang H.M., Hsu L.S., et al. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and nrf-2 antioxidant genes. Food Chem Toxicol 2012, 50:1245-1255.
16. Umesalma S., Sudhandiran G. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 2010, 107:650-655.
17. Okla M., Kang I., Kim D.M., Gourineni V., Shay N., Gu L., et al. Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms. J Nutr Biochem 2015, 26:82-90.
18. Kang I., Okla M., Chung S. Ellagic acid inhibits adipocyte differentiation through coactivator-associated arginine methyltransferase 1-mediated chromatin modification. J Nutr Biochem 2014, 25:946-953.
19. Garcia-Villalba R., Espin J.C., Aaby K., Alasalvar C., Heinonen M., Jacobs G., et al. Validated method for the characterization and quantification of extractable and nonextractable ellagitannins after acid hydrolysis in pomegranate fruits, juices, and extracts. J Agric Food Chem 2015, 63:6555-6566.
20. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
21. Chen H.C., Farese R.V. Determination of adipocyte size by computer image analysis. J Lipid Res 2002, 43:986-989.
22. Zhao L., Kang I., Fang X., Wang W., Lee M.A., Hollins R.R., et al. Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment. Int J Obes 2015, 39:438-446.
23. Kosmala M., Zdunczyk Z., Juskiewicz J., Jurgonski A., Karlinska E., Macierzynski J., et al. Chemical composition of defatted strawberry and raspberry seeds and the effect of these dietary ingredients on polyphenol metabolites, intestinal function, and selected serum parameters in rats. J Agric Food Chem 2015, 63:2989-2996.
24. Kelley G.L., Allan G., Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004, 145:548-555.
25. Zhang C., Chen X., Zhu R.M., Zhang Y., Yu T., Wang H., et al. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicol Lett 2012, 212:229-240.
26. Bhandary B., Marahatta A., Kim H.R., Chae H.J. An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. Int J Mol Sci 2012, 14:434-456.
27. Landete J. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int 2011, 44:1150-1160.
28. González-Sarrías A., García-Villalba R., Núñez-Sánchez M.A., Tomé-Carneiro J., Zafrilla P., Mulero J., et al. Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J Funct Foods 2015, 19:225-235.
29. Larrosa M., Gonzalez-Sarrias A., Yanez-Gascon M.J., Selma M.V., Azorin-Ortuno M., Toti S., et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 2010, 21:717-725.
30. Ishimoto H., Shibata M., Myojin Y., Ito H., Sugimoto Y., Tai A., et al. In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. Bioorg Med Chem Lett 2011, 21:5901-5904.
31. Tomas-Barberan F.A., Garcia-Villalba R., Gonzalez-Sarrias A., Selma M.V., Espin J.C. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J Agric Food Chem 2014, 62:6535-6538.
32. Ouyang X., Cirillo P., Sautin Y., McCall S., Bruchette J.L., Diehl A.M., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008, 48:993-999.
33. Caton P.W., Nayuni N.K., Khan N.Q., Wood E.G., Corder R. Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism. J Endocrinol 2011, 208:273-283.
34. Anhe F.F., Roy D., Pilon G., Dudonne S., Matamoros S., Varin T.V., et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015, 64:872-883.
35. Jaroslawska J., Juskiewicz J., Wroblewska M., Jurgonski A., Krol B., Zdunczyk Z. Polyphenol-rich strawberry pomace reduces serum and liver lipids and alters gastrointestinal metabolite formation in fructose-fed rats. J Nutr 2011, 141:1777-1783.
36. Yoshimura Y., Nishii S., Zaima N., Moriyama T., Kawamura Y. Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-A(y) mice. Biochem Biophys Res Commun 2013, 434:486-491.
37. Torronen R., Sarkkinen E., Tapola N., Hautaniemi E., Kilpi K., Niskanen L. Berries modify the postprandial plasma glucose response to sucrose in healthy subjects. Br J Nutr 2010, 103:1094-1097.
38. Kam A., Li K.M., Razmovski-Naumovski V., Nammi S., Shi J., Chan K., et al. A comparative study on the inhibitory effects of different parts and chemical constituents of pomegranate on alpha-amylase and alpha-glucosidase. Phytother Res 2013, 27:1614-1620.
39. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005, 63:133-157.
40. Mayes P.A. Intermediary metabolism of fructose. Am J Clin Nutr 1993, 58:754s-765s.
41. Wang Y., Viscarra J., Kim S.J., Sul H.S. Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol 2015, 16:678-689.
42. Galano A., Francisco Marquez M., Perez-Gonzalez A. Ellagic acid: an unusually versatile protector against oxidative stress. Chem Res Toxicol 2014, 27:904-918.
43. Winand J., Schneider Y.J. The anti-inflammatory effect of a pomegranate husk extract on inflamed adipocytes and macrophages cultivated independently, but not on the inflammatory vicious cycle between adipocytes and macrophages. Food Funct 2014, 5:310-318.
44. Jeong M.Y., Kim H.L., Park J., An H.J., Kim S.H., Kim S.J., et al. Rubi fructus (rubus coreanus) inhibits differentiation to adipocytes in 3T3-L1 cells. Evid Based Complement Alternat Med 2013, 2013:475386.
45. Wang L., Li L., Ran X., Long M., Zhang M., Tao Y., et al. Ellagic acid reduces adipogenesis through inhibition of differentiation-prevention of the induction of Rb phosphorylation in 3T3-L1 adipocytes. Evid Based Complement Alternat Med 2013, 2013:287534.